Does Medicare Part D Cover GLP-1 Weight Loss Medications?

You have spent decades managing your weight. You have tried diets, exercise programs, and behavioral approaches. Now, at 68, your provider mentions a GLP-1 medication that might finally help. But when you check your Medicare Part D plan, you find the medication is not covered. That can feel like one more door closing.

Here is what is actually happening with Medicare and GLP-1 weight loss medications, and what your real options are.

The Medicare Part D Weight Loss Drug Exclusion

Medicare Part D, the prescription drug coverage part of Medicare, has a specific rule written into law. Medications prescribed primarily for weight loss have been excluded from coverage since 2003, when Congress passed the Medicare Modernization Act^[1].

The exclusion was written long before GLP-1 medications existed. At that time, weight loss medications were a much smaller category. Congress wanted to prevent Medicare from covering what they considered lifestyle or cosmetic medications. The language of the law says Medicare cannot cover “drugs used to promote weight loss.”

This exclusion applies directly to medications when they are prescribed specifically and primarily for weight management in patients without other medical conditions. Medicare does not cover compounded or brand-name GLP-1 medications under this indication.

When GLP-1 Is Actually Covered by Medicare Part D

Medicare Part D coverage gets clearer when a GLP-1 medication is prescribed for a condition other than weight loss alone.

Type 2 Diabetes: Medicare Part D typically covers GLP-1 medications when prescribed for type 2 diabetes. If you have T2D and your provider prescribes a GLP-1 medication to help manage your blood sugar, that use is covered under Part D. The medication is approved by the FDA for diabetes, and that is the indication your provider documents.

However, coverage is plan-specific. Your specific Medicare Part D plan may have the medication on its formulary at a certain tier (which determines your copay). Many plans require prior authorization, meaning your provider must request approval from the plan before the pharmacy can dispense the medication. Your copay will depend on your plan’s tier structure and whether you have reached your deductible and coverage gap.

Check your Medicare plan’s formulary directly or call the plan to see if the specific GLP-1 medication you need is covered, what tier it sits on, and what prior authorization is required.

What Changed in 2024 and 2025, and What’s Coming in 2026-2027

FDA Approval for Cardiovascular Risk Reduction (2024)

In March 2024, semaglutide started being prescribed for cardiovascular risk reduction. This was based on the SELECT trial^[2], a large clinical study that showed semaglutide reduced the risk of major adverse cardiovascular events (heart attack, stroke, or cardiovascular death) by about 20% in adults with established cardiovascular disease.

This change matters for Medicare coverage. The Centers for Medicare and Medicaid Services (CMS) issued guidance clarifying that when a medication is FDA-approved for an indication other than weight loss, and a provider prescribes it for that approved indication, Medicare may cover it even if weight loss medications are generally excluded.

In practical terms, this means a Medicare beneficiary with established cardiovascular disease (heart attack, stroke, or coronary artery disease in their medical history) may have a path to coverage if their provider prescribes semaglutide specifically for cardiovascular risk reduction. The key is that the provider must document the cardiovascular indication as the primary reason for the prescription, not weight loss.

This is still plan-specific and still requires documentation. Your provider would need to note in the medical record that the prescription is for cardiovascular protection, your plan would need to accept this indication as covered, and you would need to meet your plan’s other requirements (formulary, tier, prior authorization).

The Medicare BALANCE Model (2026-2027): A Major Policy Shift

The most significant change is coming with the launch of the Medicare BALANCE Model. In January 2026, CMS formally announced this voluntary payment model that fundamentally changes Medicare’s approach to covering anti-obesity medications.

What it is: The BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model enables Medicare Part D plans to cover GLP-1 medications (semaglutide, tirzepatide) specifically for weight management as a primary indication. This reverses decades of Medicare policy excluding weight loss medications.

Timeline:

• July 2026: A bridge program begins, allowing early Medicare beneficiary access
• January 2027: Full implementation of the BALANCE Model launches

Who qualifies: Medicare beneficiaries with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with weight-related conditions.

Your cost: $50 per month for GLP-1 medications. All beneficiaries also receive access to manufacturer-provided lifestyle support programs at no additional cost.

What this means for you: If you are a Medicare beneficiary interested in GLP-1 medications for weight management, you will have a new pathway to coverage beginning in 2027. For the first time in Medicare history, weight management will be a covered indication.

For patients currently paying out of pocket or using compounded GLP-1s: The BALANCE Model creates an opportunity to transition to Medicare-covered branded GLP-1 medications starting July 2026 if you meet the eligibility criteria.

Medicare Advantage and Plan Variation

If you have Medicare Advantage (Part C) instead of Original Medicare with a separate Part D plan, your coverage rules may be different.

Medicare Advantage plans are private insurance plans that cover Part A and Part B benefits and often include prescription drug coverage. Some Medicare Advantage plans offer supplemental benefits beyond what Original Medicare requires. These supplemental benefits can include coverage for weight management medications.

If you have a Medicare Advantage plan with prescription drug coverage, check your plan’s formulary and extra benefits section. Some plans may cover weight management medications under their supplemental benefit structure, even if the medication would be excluded under traditional Part D rules.

Call your Medicare Advantage plan directly and ask whether GLP-1 medications for weight management are covered as a supplemental benefit.

What to Do If You Cannot Access Medicare Coverage

You have several paths if your Medicare plan does not cover GLP-1 for your situation.

First, confirm your situation: Check with your provider and your Part D or Medicare Advantage plan about whether you have T2D (which may qualify for coverage) or established cardiovascular disease (which may qualify under the SELECT trial indication). If your provider has not documented either of these, ask whether they apply to you and whether documentation could change your coverage status.

If you have type 2 diabetes: Work with your provider to request prior authorization for a GLP-1 medication from your plan. Different plans have different approval processes, and some medications are covered on certain tiers. Your provider’s office usually handles prior authorization; they can often get a decision within days.

If you do not have T2D or cardiovascular disease: You are likely not eligible for Medicare Part D coverage under the weight loss exclusion. This is where a cash-pay program becomes an option.

Consider a cash-pay compounded GLP-1 program: Transformation Health offers an all-inclusive program starting at $249-339/month that covers medication, provider evaluation, lab work, and medical coaching. You pay out-of-pocket, but there is no insurance hassle, no prior authorization, and no waiting for plan approvals. The medication is prepared by a licensed US compounding pharmacy.

Importantly, Medicare does not cover compounded medications, and Medicare Supplement (Medigap) or Medicare Advantage plans do not cover compounded telehealth programs. But if paying cash is feasible for you, it removes the insurance complexity entirely.

Using HSA Funds on Medicare

There is a common misconception about HSAs and Medicare that deserves clarification.

Once you enroll in Medicare, you can no longer make contributions to a health savings account. This is a hard rule. The moment you are enrolled in any part of Medicare (including Part A), you become ineligible to contribute to an HSA^[3].

However, if you already have money in an HSA before enrolling in Medicare, you can continue to use those funds for eligible medical expenses, including prescription medications and related medical services. The funds do not disappear or become inaccessible just because you are on Medicare. You simply cannot add new money to the account.

If you are considering a cash-pay GLP-1 program and have existing HSA funds, you may be able to use those funds to cover the cost. Consult your HSA plan administrator or a tax advisor to confirm that your specific program qualifies as an eligible medical expense under your plan’s rules.

Your Next Steps

If you are a Medicare beneficiary interested in GLP-1 weight loss treatment, here is what to do:

1. Check your coverage status: Contact your Medicare Part D or Medicare Advantage plan and ask whether GLP-1 medications are covered for your specific situation. If you have type 2 diabetes, ask about coverage under that indication. If you have cardiovascular disease, ask about coverage under the SELECT trial cardiovascular indication. Get specific information about formulary status, coverage tier, prior authorization requirements, and typical copay amounts.

2. Talk to your provider: Tell your provider you are interested in GLP-1 treatment. If you have diabetes, your provider can start the authorization process. If you do not have diabetes but have cardiovascular disease, ask your provider whether a cardiovascular indication applies to you and whether the provider would document it.

3. Evaluate cash-pay options if needed: If your plan does not cover GLP-1, a cash-pay program with a licensed provider may be a realistic option. All-inclusive pricing ($249-339/month) covers medication, provider oversight, lab work, and coaching.

4. Confirm HSA eligibility (if applicable): If you have an HSA with existing funds, check with your plan administrator about using those funds for medication and medical services.

Citations

[1] Social Security Administration. “Title XVIII of the Social Security Act - Medicare.” https://www.ssa.gov/OP_Home/ssact/title18/1860D-02.htm

[2] Lincoff AM, et al. “Semaglutide and Cardiovascular Outcomes in Obesity Without Previous Cardiovascular Disease.” New England Journal of Medicine. 2023. https://pubmed.ncbi.nlm.nih.gov/37952131/

[3] U.S. Internal Revenue Service. “Publication 502: Medical and Dental Expenses.” https://www.irs.gov/publications/p502